H. Xu, D. Wang, C. Ramponi, X. Wang, and H. Zhang, “The P21-Activated Kinase 1 and 2 As Potential Therapeutic Targets for the Management of Cardiovascular Disease”, IJDDP, vol. 1, no. 1, p. 5, Dec. 2022. doi: 10.53941/ijddp.v1i1.179.